Application of 4, 4′-Diaminobenzanilide Schiff Base Metal Complexes as Anti-Tumor and Anti-Dengue Agents
J. Environ. Nanotechnol., Volume 9, No 1 (2020) pp. 11-20
Abstract
A unique Schiff base ligand 4-(4-nitrobenzylideneamino)-N-(4-(4-nitroobenzy lideneamino) phenyl) benzamide L has been prepared by condensing 4,4′-diaminobenzanilide and p-nitrobenzaldehyde. The cobalt (II), nickel (II) and copper (II) complexes of L were also prepared. 1H-NMR, FT-IR, UV-Vis., EPR and EI-mass techniques were used to confirm the formation and structure of the ligand and its complexes. Using Auto Dock vina and Discovery studio software, the synthesized complexes were docked with Human DNA topoisomerase I (PDB: 1SC7) and Dengue NS3 protease-helicase (PDB ID: 2VBC). The biological applications of the synthesized complexes were carried out by Cytotoxic screening analysis and DNA binding ability by using electronic spectra and Anti-Tumor activity by MTT assay. The results established that the synthesized transition metal complexes can act as good anti-tumor and anti-dengue agents.
Full Text
Reference
Abbaspour, A., Esmaeilbeig, A. R., Jarrahpour, A. A., Khajeh, B. and Kia, R., Aluminium(III)-selective electrode based on a newly synthesized tetradentate Schiff base, Talanta, 58(2), 397–403 (2002).
https://dx.doi.org/10.1016/S0039-9140(02)00290-4
Abdulghani, A. J. and Mohuee, S. K., Synthesis and Characterization of New Schiff Bases Derived from Ceftriaxone Sodium with 1H- Indole-2, 3-Dione (Isatin) and 1-Acetyl Indoline-2, 3-Dione (N-Acetylisation) and their Platium(IV) complexes’, J. Chem. Biological. Phys. Sci., 6(2), 579-595 (2016).
Alagesan, M., Bhuvanesh, N. S. P. and Dharmaraj, N., An investigation on new ruthenium (II) hydrazone complexes as anticancer agents and their interaction with biomolecules, Dalton Trans., 43, 6087-6099 (2014).
https://dx.doi.org/10.1039/C3DT51949J
Aoyama, Y., Konoike, T., Kanda, A., Naya, N. and Nakajima, M., Total synthesis of human chymase inhibitor methyllinderone and structure–activity relationships of its derivatives, Bioorg. Med. Chem. Lett., 11(13), 1695–1697 (2001).
https://dx.doi.org/10.1016/s0960-894x(01)00265-7
Aoyama, Y., Uenaka, M., Kii, M., Tanaka, M., Konoike, T., Hayasaki - Kajiwara Y., Naya N. and Nakajima, M., Design, synthesis and pharmacological evaluation of 3-benzylazetidine-2-one-based human chymase inhibitors, Bioorg. Med. Chem., 9(11), 3065–30759 (2001).
https://dx.doi.org/10.1016/s0968-0896(01)00209-7.
Aoyama Y., Uenaka M., Konoike T., Hayasaki-Kajiwara Y., Naya N. and Nakajima M., Inhibition of serine proteases: activity of 1, 3-Diazetidine-2, 4-diones, Bioorg. Med. Chem. Lett., 11(13), 1691–1694 (2010).
https://dx.doi.org/10.1016/s0960-894x(01)00264-5.
Aoyama, Y., Uenaka, M., Konoike, T., Iso, Y., Nishitani, Y., Kanda, A., Naya, N. and Nakajima M., Synthesis and structure-activity relationships of a new class of 1-oxacephem-based human chymase inhibitors, Bioorg. Med. Chem. Lett., 10(21), 2397–2401 (2000).
https://dx.doi.org/10.1016/s0960-894x(00)00488-1.
Asadi, Mozaffar, Elham Safaei, Bijan Ranjbar and Leila Hasani, Thermodynamic and spectroscopic study on the binding of cationic Zn(II) and Co(II) tetrapyridinoporphyrazines to calf thymus DNA: the role of the central metal in binding parameters, New J. Chem., 28(10), 1227-1234 (2004).
https://dx.doi.org/10.1039/B404068F
Bas, D. C., Rogers, D. M. and Jensen, J. H., Very fast prediction and rationalization of pKa values for protein-ligand complexes, Proteins Struct. Funct. Genet., 73(3), 765–783 (2008).
https://dx.doi.org/10.1002/prot.22102
Chen L. S. and Sue C. Cummings, Synthesis and characterization of cobalt (II) and some nickel (II) complexes with N, N!-ethylenebis (pX-benzoylacetone iminato) and N, N!-ethylenebis (pX-benzoylmonothioacetone iminato) ligands, J. Inorg. Chem., 17(9), 2358-2361 (1978).
https://dx.doi.org/10.1021/ic50187a005
Del Paggio, Alan A and David R. McMillin, Substituent effects and the photoluminescence of Cu(PPh3)2(NN)+ systems, J. Inorg. Chem., 22(4), 691-692 (1983).
https://dx.doi.org/10.1021/ic00146a024
Geary, W. J., The use of conductivity measurements in organic solvents for the characterisation of coordination compounds, Coord. Chem. Rev., 7 81-122 (1971)
http://dx.doi.org/10.1016/S0010-8545(00)80009-0
Greco, M. N., Hawkins M. J., Powell, E. T., Almond, H. R., Garavilla, L., Hall, J., Minor, L. K., Wang Y., Corcoran, T. W., Cera, E. D., Cantwell, A. M., Savvides, S.N., Damiano, B. P. and Maryanoff, B. E., Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase, J Med. Chem., 50(8), 1727–1730 (2007).
https://dx.doi.org/10.1021/jm0700619
Greenwood, J. R., Calkins, D., Sullivan, A. P. and Shelley, J. C., Towards the comprehensive, rapid, and accurate prediction of the favorable tautomericstates of drug-like molecules in aqueous solution, J. Comput. Aided Mol. Des., 24(6-7), 591–604 (2004).
https://dx.doi.org/10.1007/s10822-010-9349-1
Hayashi, Y., Iijima, K., Katada, J. and Kiso, Y., Structure-activity relationship studies of chloromethyl ketone derivatives for selective human chymase inhibitors. Bioorg. Med. Chem. Lett., 10, 199-201(2000).
https://dx.doi.org/10.1016/s0960-894x(99)00659-9
Herebian, Diran and William S. Sheldrick, Synthesis and DNA binding properties of bioorganometallic (η 5-pentamethylcyclopentadienyl) iridium (III) complexes of the type [η5-C5Me5) Ir (Aa)(dppz)] n+ (dppz=dipyrido [3,2-a:2’,3’-c] phenazine, n=1-3), with S-coordinated amino acids (Aa) or peptides’, J. Chem. Soc., Dalton Trans., 6, 966-974(2002).
https://dx.doi.org/10.1039/B107656F
Iijima, K., Katada, J. and Hayashi, Y., Symmetrical anhydridetype serine protease inhibitors:structure-activity relationship studies of human chymase inhibitors, Bioorg. Med. Chem. Lett., 9(3), 413–418 (1999).
https://dx.doi.org/10.1016/s0960-894x(99)00012-8
Iijima, K., Katada, J., Yasuda, E., Uno, I. and Hayashi, Y., N-[2,2- Dimethyl-3-(N-(4-Cyanobenzoyl)Amino)Nonanoyl]-L-Phenylalanine ethyl ester as a stable ester-type inhibitor of chymotrypsin-like serine proteases: structural requirements for potent inhibition of a-chymotrypsin., J. Med. Chem., 42(2), 312–323 (1999).
